Tag: daratumumab

amyloid_650x450
November 17, 2021/Research

Adding Daratumumab to Treatment Regimen May Improve Outcomes in Patients With Immunoglobulin Light-Chain Amyloidosis

Study associates human CD38-targeting antibody with fewer complications

650×350-Chemotherapy
May 6, 2020/Research

Research Shows Daratumumab’s Effectiveness in AL Amyloidosis

Study finds good hematologic response and rapid action

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad